Home/Tag:HAART 200

HAART 200 Design Rationale

BioStable HAART 200 Aortic Annuloplasty Device - Simplifying BAV Repair with Three-Dimensional Annuloplasty. In the inaugural issue of HAARTbeat, we explained how the HAART 300 device was developed from CT angiography studies of normal aortic valves and is designed to create normal three-dimensional annular shape based on leaflet sizing. In BAV disease, there is no such thing as “normal” annular shape and the presentation of the anatomy can be highly variable.

2018-12-04T13:09:09+01:00November 25th, 2018|HAARTbeat|

HAART 200 First Commercial Use

BioStable Science & Engineering, Inc. announced today the first commercial use of the HAART 200 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia. Drs. Lawrence Wei, Vinay Badhwar and J. Scott Rankin were the collaborating surgeons for the procedure.

2018-12-07T17:37:01+01:00September 26th, 2017|Press Release|

HAART 200 Receives FDA Clearance

BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 200 Aortic Annuloplasty Device, the first and only annuloplasty device designed specifically for bicuspid aortic valve repair.

2018-12-07T17:39:08+01:00August 15th, 2017|Press Release|
Go to Top